insights_auto
Why is CSJA down 3,27%?
Dive Deeperchevron_right
CSJA:FRA
CSL ADR
29,60 €
arrow_downward
-3,27%(-1,00) 1D
13-ноя., 08:07:50 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSJA...
Open
29,60 €
High
29,60 €
Low
29,60 €
Mkt. cap
97,38 млд
Avg. vol.
0,00
Volume
0,00
52-wk high
43,40 €
52-wk low
12,70 €
No. of employees
29 миң
Open
29,60 €
High
29,60 €
Low
29,60 €
Mkt. cap
97,38 млд
Avg. vol.
0,00
Volume
0,00
52-wk high
43,40 €
52-wk low
12,70 €
No. of employees
29 миң
News stories
From web sources and news partners
Medical Republic
·
4 саат мурун
Q fever vaccine stocks set to run dry
Kalkine
·
8 саат мурун
CSL Limited Buys Back 35,318 Shares on 12 November 2026 in On-Market Program
TheBull.com.au
·
13 саат мурун
CSL Shares At 52Wk Highs: Can The Rally Stretch To Sixth Months?
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees29 миң
Founded1916
HeadquartersМельбурн, Виктория, Австралия
SectorHealth Care
Industry-
Websitecsl.com